Filing Flows › Comparisons › NTLA vs AWHL
Intellia Therapeutics vs Aspira Women's Health: NTLA and AWHL compared
Intellia Therapeutics is the larger company: $7.2M of revenue in its latest quarter (Q3 2026) against $2.0M for Aspira Women's Health (Q2 2026). Aspira Women's Health is growing faster (-15% against -48% a year earlier).
Where the money goes: NTLA and AWHL
Intellia Therapeutics (NTLA) · Q3 2026
Intellia Therapeutics, Q3 2026: revenue $7.2M (-48% year over year), net loss $127M, operating cash flow −$85.4M. The chart follows the revenue to costs, profit and cash.
Aspira Women's Health (AWHL) · Q2 2026
Aspira Women's Health, Q2 2026: revenue $2.0M (-15% year over year), operating margin -89.7%, net loss $2.4M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
| Intellia Therapeutics (NTLA) | Aspira Women's Health (AWHL) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $7.2M | $2.0M |
| Revenue growth, Y/Y | -48% | -15% |
| Operating margin | n/m | -89.7% |
| Net earnings | −$127M | −$2.4M |
| Net margin | — | -118.3% |
| Operating cash flow | −$85.4M | −$2.0M |
Questions
Which is bigger, Intellia Therapeutics or Aspira Women's Health?
Intellia Therapeutics is the larger company: $7.2M of revenue in its latest quarter (Q3 2026) against $2.0M for Aspira Women's Health (Q2 2026).
Is Intellia Therapeutics or Aspira Women's Health growing faster?
Aspira Women's Health is growing faster (-15% against -48% a year earlier).
More: Intellia Therapeutics earnings · how Intellia Therapeutics makes money · Aspira Women's Health earnings · how Aspira Women's Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.